MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Neuraxis (NRXS) Ownership - Who owns Neuraxis?

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

Profile

Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.47M
P/E Ratio
N/A
Total Cash
5.99M
Projected Growth
N/A
Total Debt
410.48K
Revenue
3.22M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.60
Total Debt/Equity
N/A
Revenue/Share
0.43 USD as % of share price

Fundamentals

NRXS
Capitalization
23.5M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
5.99M
Total Cash/Share
0.60
Total Debt
410K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.43%
Revenue
3.22M
ROE
N/A
Book Value
4.25M
P/B Ratio
5.52
Cash Flow
N/A
Earnings
-1.05
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.86K
Current Ratio
2.82
Current Revenue Per Employee
42575.52
Dividends Per Share - Security
N/A
EBITDA
-7.01M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.60
Revenue To Assets
-160.56
Shares Held By Institutions
2.13M
Shares Outstanding - Current
9.99M
Total Liabilities
2.84M
Total Volume MTD
N/A
Value
N/A
Gain YTD
0.000
View a ticker or compare two or three
NRXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com